Abstract：Objective To investigate and analyze the incidence and risk factors of chemotherapy induced fatigue in elderly lung
cancer patients. Method 120 elderly lung cancer patients admitted to our hospital from March 2020 to March 2023 were selected as the
survey subjects. All patients received unified chemotherapy treatment and were evaluated using the Piper fatigue scale. The number of
patients with cancer induced fatigue was counted and the incidence of fatigue was calculated. According to the occurrence of fatigue in
patients they were divided into a fatigue group and a normal group and the risk factors of cancer induced fatigue in elderly lung
cancer patients undergoing chemotherapy were analyzed using univariate and multivariate logistic regression. Result Out of 120 elderly
lung cancer patients 79 patients experienced cancer induced fatigue fatigue with an incidence rate of 65. 83%. The patients were
divided into a fatigue group 79 cases and a normal group 41 cases . Univariate analysis showed that the age tumor stage basic
disease history and incidence of complications of the fatigue group were higher than those of the normal group while serum albumin
ALB was lower than that of the normal group P < 0. 05 . Multivariate analysis shows that advanced age high tumor staging
comorbidities with underlying diseases complications and low ALB are independent risk factors for cancer related fatigue in elderly
patients with lung cancer undergoing chemotherapy. Conclusion Elderly lung cancer patients generally experience cancer induced
fatigue symptoms during chemotherapy among which advanced age high tumor staging comorbidities with underlying diseases
complications and low ALB are independent risk factors for the occurrence of cancer induced fatigue.
项克梅,骆 甜,李盼盼. 老年肺癌化疗癌因性疲乏的危险因素分析[J]. 肿瘤代谢与营养电子杂志, 2024, 11(3): 339-343.
Xiang Kemei, Luo Tian, Li Panpan. Risk factors analysis of cancer induced fatigue in elderly patients with lung cancer undergoing chemotherapy. Electron J Metab Nutr Cancer, 2024, 11(3): 339-343.
